72180-26-8

Basic information

• Product Name: （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb
• Synonyms: （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb;(S)-1-benzyl 2-methyl 4,4-difluoropyrrolidine-1,2-dicarboxylate;(S)-1-Benzyl-2-methyl-4,4-difluoropyrrolidine-1,2-dicarboxylic acid;(2S)-4,4-difluoro-1,2-Pyrrolidinedicarboxylic acid 2-methyl 1-(phenylmethyl) ester;(S)-1-Carbobenzoxy-4,4-difluoropyrrolidine-2-carboxylic acid methyl ester
• CAS NO: 72180-26-8
• Molecular Formula: C₁₄H₁₅F₂NO₄
• Molecular Weight: 299.272
• Mol File: 72180-26-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 378.2±42.0 °C(Predicted)
• Appearance: /
• Density: 1.31±0.1 g/cm3(Predicted)
• Refractive Index: 1.525
• PKA: -8.05±0.60(Predicted)
• CAS DataBase Reference: （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb(CAS DataBase Reference)
• NIST Chemistry Reference: （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb(72180-26-8)
• EPA Substance Registry System: （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb(72180-26-8)

Safety Data

• Hazardous Substances Data: 72180-26-8(Hazardous Substances Data)

Usage

General Description

（S）-1-benzyl-2-methyl-4,4-difluoropyrrolidine-1,2-dicarb is a chemical compound with the molecular formula C15H18F2N2O2. It is a pyrrolidine derivative that contains a benzyl group, a methyl group, and two fluorine atoms. （s）-1-benzyl-2-methyl-4，4-difluoropyrrolidine-1，2-dicarb is a dicarbonyl derivative, meaning it contains two carbonyl groups. It can be used in organic synthesis and pharmaceutical research as a building block or intermediate for the production of various compounds. Its unique structure and functional groups make it a versatile and valuable compound in chemical and pharmaceutical industries. Further research and applications of this compound may offer new insights and opportunities in drug development and other fields.

InChI:InChI=1/C14H15F2NO4/c1-20-12(18)11-7-14(15,16)9-17(11)13(19)21-8-10-5-3-2-4-6-10/h2-6,11H,7-9H2,1H3

Upstream product

• 64187-47-9 1-benzyloxycarbonyl-4-keto-L-proline 
• 16217-15-5 1-benzyloxycarbonyl-4-oxo-L-proline methyl ester 

Relevant articles and documents

BENZIMIDAZOLE-LINKED INDOLE COMPOUND ACTING AS NOVEL DIVALENT IAP ANTAGONIST

The present invention discloses a benzimidazole-linked indole compound acting as novel divalent IAP antagonist, specifically disclosing the compound shown in fomulas (I) or a pharmaceutically acceptable salt thereof.

(Phosphinyloxy)acid amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-Amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]- L-proline

Analogues of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]- L-proline (1, SQ 29,852) in which the terminal proline residue has been replaced by a variety of substituted and heteroatom-substituted prolines, N-arylglycines, N-cycloalkylglycines, and bicyclic amino acids have been synthesized and evaluated as inhibitors of angiotensin converting enzyme in vitro an in vivo. In general, the addition of lipophilic substituents to the 4-position of proline of the parent phosphate 1 resulted in substantial increases in vitro activity. The largest improvements were observed in the case of cis-benzyl (36-fold) and dithioketal (24-fold) analogues 2r and 2x, respectively. These enhancements of in vitro activity were accompanied by modest increases (2-3.5-fold) in in vivo (iv) activity. Among the various terminal amino acid replacements examined in this study, the indoline-based analogue 2i was by far the most potent compound on iv administration in the normotensive rat.